Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cardeon raises $22 million to support COBRA trial

This article was originally published in Clinica

Executive Summary

Private company Cardeon has closed a $22 million series D funding round. The company, which makes products aimed at minimizing the risk of the adverse effects of cardiac surgery, will use the funds to continue its clinical trial and to prepare for the European launch of its first product, the COBRA catheter. The product is an investigational device pending FDA approval for general clinical use.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT074476

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel